FY2027-Q1 revenue was ¥30.985 billion and operating profit was ¥4.592 billion, representing increases in both revenue and profit, while the full-year operating profit forecast is ¥25.5 billion, down 4.2% year on year. In FY2027-H1, progress and margins need to be checked to determine whether first-quarter earnings growth will support achievement of the full-year forecast.
All recorded disclosures and news since the latest annual or semiannual filing. Switching watchpoints keeps the full history. Select an item to inspect its source.2026-06-26 〜 2026-10-25 · 15 of 15 items
Scroll the timeline →
Will the revenue progress rate against the full-year forecast rise from 21.8% to 25.0%?
Will the operating profit progress rate against the full-year forecast move from 18.0% toward 25.0%?
Will first-half revenue exceed ¥71 billion, equivalent to half the full-year forecast?
Will first-half operating profit exceed ¥12.75 billion, equivalent to half the full-year forecast?
Will the full-year revenue forecast of ¥142 billion and operating profit forecast of ¥25.5 billion be maintained?
The company's ongoing themes and initiatives this watchpoint touches on.
FY2027-Q1 revenue was ¥30.985 billion, up 2.0% year on year; operating profit was ¥4.592 billion, up 9.9%; ordinary income was ¥4.867 billion, up 11.5%; and net income attributable to owners of the parent was ¥3.079 billion, up 8.8%. Operating profit grew faster than revenue, with the first-quarter operating margin improving to approximately 14.8% from approximately 13.8% a year earlier, an improvement of approximately 1.1 percentage points.
The company's FY2027 full-year forecasts are revenue of ¥142 billion, operating profit of ¥25.5 billion, ordinary income of ¥25.5 billion and net income attributable to owners of the parent of ¥17.7 billion. The respective changes from the previous fiscal year's results are forecasts of 1.6% growth, 4.2% decline, 6.7% decline and 5.8% decline. FY2026 results were revenue of ¥139.697 billion, operating profit of ¥26.608 billion, ordinary income of ¥27.341 billion and net income of ¥18.790 billion. Thus, the current-year plan calls for revenue growth while keeping earnings below the previous year's levels. First-quarter earnings growth alone does not indicate a change to the full-year earnings decline plan, and the effects of costs, product mix, foreign exchange and the external environment need to be assessed from the first half onward.
Progress against the full-year forecast in the first quarter was 21.8% for revenue and 18.0% for operating profit. With simple quarterly linearity, 25.0% would be the benchmark, but this is a comparison benchmark rather than the company plan because medical equipment is affected by the timing of business negotiations and seasonality in the rental business. In FY2027-H1, using revenue of ¥71 billion and operating profit of ¥12.75 billion as simple half-year benchmarks, we will assess how much greater the dependence on the second half becomes if actual results fall below these levels, and whether the full-year forecasts are revised.
¥ millions
Select a value or step to inspect its source.
Ordered by date. Disclosures and financial records differ from news and company threads; open each source to inspect it.
2026-10-30 · Awaiting publication
· Awaiting publication
The prior-year comparison for this event
2025-10-31 disclosed · In ¥ millions; each quarter is cumulative from the start of the fiscal year. EPS is in yen.
Latest available: FY2027 Q1
Net salesBusiness scale
64,807JPY m
↗ +0.8% YoYOperating profitCore earnings
10,663JPY m
↗ +0.1% YoYNewest first. The highlighted column is this event’s comparison. YoY uses the same period and accounting basis.
| Metric | FY2027 Q1 | FY2026 full year | FY2026 Q3 | FY2026 Q2Comparison | FY2026 Q1 | FY2025 full year | FY2025 Q3 | FY2025 Q2 |
|---|---|---|---|---|---|---|---|---|
| Net sales | 30,985↗ +2.0% YoY | 139,697↗ +0.5% YoY | 98,857↘ -0.5% YoY | 64,807↗ +0.8% YoY | 30,376YoY unavailable | 139,007YoY unavailable | 99,395YoY unavailable | 64,314YoY unavailable |
| Operating profit | 4,592↗ +9.9% YoY | 26,608↗ +2.8% YoY | 16,400↘ -5.7% YoY | 10,663↗ +0.1% YoY | 4,179YoY unavailable | 25,874YoY unavailable | 17,392YoY unavailable | 10,654YoY unavailable |
| Ordinary profit | 4,867↗ +11.6% YoY | 27,341↗ +2.7% YoY | 16,762↘ -6.8% YoY | 10,926↘ -3.0% YoY | 4,363YoY unavailable | 26,633YoY unavailable | 17,990YoY unavailable | 11,262YoY unavailable |
| Net income | 3,079↗ +8.8% YoY | 18,790↗ +1.0% YoY | 11,726↘ -5.2% YoY | 7,578↘ -1.7% YoY | 2,829YoY unavailable | 18,605YoY unavailable | 12,374YoY unavailable | 7,706YoY unavailable |
| Earnings per share | 113.97↗ +13.0% YoY | 683.41↗ +5.9% YoY | 425.16↘ -1.0% YoY | 273.47↗ +2.3% YoY | 100.87YoY unavailable | 645.41YoY unavailable | 429.25YoY unavailable | 267.34YoY unavailable |